LNP screening platform
Self-developed LNP platform mainly utilizes internal ionizable lipid library guided with machine learning;
Pipeline specific and multi-dimension screen results are fed back to algorithm platform to further guide next round molecule design and screen;
Besides self-developed platform, NeoCura is also collaborated with Integrated Therapeutics to explore new generations of LNP delivery system.
Novel carrier delivery platform
Exosome platform is built mainly through collaboration with renowned exosome delivery company, MDImmune to explore exosome tech application on mRNA delivery;
VLP, polymer and other delivery platforms are internally developed platform rapidly, while seeking multiple possible collaboration simultaneously.
NeoCura bases on self-owned LNP screen platform and is actively laying out new delivery carrier platform, including exosomes, VLP, polymers and so on.
